Five Questions With: Dr. Stephen Salloway

By
-
DR. STEPHEN SALLOWAY is the director of neurology and the Memory and Aging Program at Butler Hospital. / COURTESY CARE NEW ENGLAND
Dr. Stephen Salloway heads the neurology department and Memory and Aging Program at Butler Hospital, where, as part of a study, some patients have been taking an investigational drug for Alzheimer’s disease since 2013. Biogen, the maker of the drug, halted further research at one point but reversed course and recently announced that it will…

Register to keep reading or subscribe today and receive unlimited access.
Register Now Already a Subscriber? Login now

If you have already logged in and are still seeing this message, please refresh the page as your browser is caching the old content.

Purchase NowWant to share this story? Click Here to purchase a link that allows anyone to read it on any device whether or not they are a subscriber.

RELATED ARTICLESMORE FROM AUTHOR